Publicacións en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (16)

2023

  1. Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension

    American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158

  2. Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature

    Genes, Vol. 14, Núm. 10

  3. Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension

    Revista Espanola de Cardiologia, Vol. 76, Núm. 6, pp. 460-467

2022

  1. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 3, pp. 489-500

  2. First Genotype-Phenotype Study in TBX4 Syndrome Gain-of-Function Mutations Causative for Lung Disease

    American Journal of Respiratory and Critical Care Medicine, Vol. 206, Núm. 12, pp. 1522-1533

2021

  1. Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease

    Cells, Vol. 10, Núm. 6

  2. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  3. The coronavirus disease 2019 (Covid-19): Key emphasis on melatonin safety and therapeutic efficacy

    Antioxidants, Vol. 10, Núm. 7

  4. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients

    Scientific Reports, Vol. 10, Núm. 1

  2. Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4

    PLoS ONE, Vol. 15, Núm. 4

  3. Understanding the oncostatic actions displayed by melatonin in colorectal cancer therapy

    Future Medicinal Chemistry, Vol. 12, Núm. 13, pp. 1201-1204

2019

  1. Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 44, pp. 22300-22306

  2. Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics

    Cancers, Vol. 11, Núm. 11

2018

  1. Melatonin: A hypothesis for Kawasaki disease treatment

    Medical Hypotheses, Vol. 119, pp. 6-10

2007

  1. Prolactin-releasing peptide (PrRP) increases prolactin responses to TRH in vitro and in vivo

    Endocrine, Vol. 31, Núm. 2, pp. 119-124